NCT05242419View on ClinicalTrials.gov

A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 10, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

December 30, 2025

Conditions
InjectionNon-cardiac SurgeryDelirium in Old AgePost Operative Delirium
Interventions
DRUG

Sodium Chloride Injection

0.9% Sodium Chloride Injection

DRUG

Huperzine A Injection

Huperzine A Injection

Trial Locations (1)

325000

RECRUITING

The 2nd Second Affiliated Hospital of WMU Phase I Clinical Trial Unit /Center Of Bioequivalence Study, Wenzhou

All Listed Sponsors
collaborator

Affiliated Wenling Hospital of Wenzhou Medical University

OTHER

lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER